ARTIST: Loco-regional Anaesthesia in Video or Robot-assisted Thoracic Pulmonary Surgery

Sponsor
Société Française d'Anesthésie et de Réanimation (Other)
Overall Status
Recruiting
CT.gov ID
NCT05126524
Collaborator
(none)
400
26
23.9
15.4
0.6

Study Details

Study Description

Brief Summary

Currently, there is no data on the part and type of Loco-regional Anaesthesia used for Video or Robot-assisted Thoracic Pulmonary Surgery.

The aim of this epidemiological study is to identify, 6 months after the publication of the SFAR / SFCTCV 2019 recommendations, the proportion and type of Loco-regional Anaesthesia used in Video or Robot-assisted Thoracic Pulmonary Surgery within French teams.

Condition or Disease Intervention/Treatment Phase
  • Other: NO INTERVENTION

Detailed Description

Currently, there is no data on the part and type of Loco-regional Anaesthesia used for Video or Robot-assisted Thoracic Pulmonary Surgery. The experience and habits of each team taking charge of the perioperative period seem to be the determining factors for the achievement of one type of Loco-regional Anaesthesia over another.

The aim of this epidemiological study is to identify, 6 months after the publication of the SFAR / SFCTCV 2019 recommendations, the proportion and type of Loco-regional Anaesthesia used in Video or Robot-assisted Thoracic Pulmonary Surgery within French teams.

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Loco-regional Anaesthesia in Video or Robot-assisted Thoracic Pulmonary Surgery
Actual Study Start Date :
Jan 4, 2021
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Loco-regional Anaesthesia in Video or Robot-assisted Thoracic Pulmonary Surgery

Patients with loco-regional Anaesthesia in Video or Robot-assisted Thoracic Pulmonary Surgery are eligible for this study

Other: NO INTERVENTION
Observational study, no intervention performed

Outcome Measures

Primary Outcome Measures

  1. to assess the incidence of locoregional anesthesia in video or robot-assisted thoracic pulmonary surgery [At least, 6 months after the publication of the SFAR / SFCTCV 2019 recommendations concerning this topic]

    Information concerning locoregional anesthesia in video or robot-assisted thoracic are recorder in the CRF

Secondary Outcome Measures

  1. Epidemiology of anaesthesia management during Video or Robot-assisted Thoracic Pulmonary Surgery [At least, 6 months after the publication of the SFAR / SFCTCV 2019 recommendations concerning this topic]

    Information concerning locoregional anesthesia in video or robot-assisted thoracic are recorder in the CRF

  2. Epidemiology of perioperative morbidity and mortality [At least, 6 months after the publication of the SFAR / SFCTCV 2019 recommendations concerning this topic]

    nformation concerning lmorbidity and mortality are recorder in the CRF

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or female aged 18years and over

  • Wedge surgery or lobectomy planned with Video or Robot-assisted surgery.

  • non-opposition of the patient to participating in the research

Exclusion Criteria:
  • Patient's refusal to use his data for research

  • Emergency surgery

  • Surgery with planned thoracotomy

  • Contraindications to performing locoregional anesthesia

  • Individual deprived of liberty or placed under the authority of a tutor

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU d'Angers Angers France 49100
2 Hôpital Privé d'Antony Antony France 92160
3 Clinique de l'Infirmerie Protestante de Lyon Caluire-et-Cuire France 69300
4 centre de Lutte Contre le Cancer Jean Perrin Clermont-Ferrand France 63011
5 Chu Dijon Dijon France 21000
6 CHU de Grenoble La Tronche France 38700
7 Hôpital Marie Lannelongue Le Plessis-Robinson France 92350
8 CHRU de Lille _Clinique Cardiothoracique et Vasculaire Lille France 59000
9 CHU Limoges Limoges France 87000
10 Centre Leon Bérard Lyon France 69008
11 Hôpital Nord Marseille Marseille France
12 Hôpital Arnaud de Villeneuve Montpellier France 34295
13 CHRU de Nancy Nancy France 54511
14 CHU Nantes - Réa CTCV de l'HGR Nantes France 44093
15 CHR d'ORLEANS Orléans France 45100
16 Institut Mutualist Montsouris - Paris Paris France 75014
17 Hôpital Européen Georges Pompidou Paris France 75015
18 Hôpital Bichat Paris France 75018
19 Hôpital TENON Paris France 75020
20 CHU de Poitiers Poitiers France 83021
21 Hôpital Privé Claude Galien Quincy-Sous-Sénart France 91480
22 CHU de Rennes, Hôpital de Pontchaillou Rennes France 35 033
23 Polyclinique Saint Laurent Rennes France 35700
24 CHU Charles Nicolle Rouen France 76000
25 Centre Hospitalier de Toulon Toulon France 83000
26 HIA Sainte-Anne - Toulon Toulon France 83800

Sponsors and Collaborators

  • Société Française d'Anesthésie et de Réanimation

Investigators

  • Study Chair: Grégoire LE GAC, MD, CHU de Rennes, Hôpital de Pontchaillou

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Société Française d'Anesthésie et de Réanimation
ClinicalTrials.gov Identifier:
NCT05126524
Other Study ID Numbers:
  • NR-2021-01
First Posted:
Nov 19, 2021
Last Update Posted:
May 9, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Société Française d'Anesthésie et de Réanimation

Study Results

No Results Posted as of May 9, 2022